January 10, 2022

Maze Therapeutics

Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically Defined Diseases

January 10, 2022

Magenta Therapeutics

Magenta Therapeutics Highlights Recent Pipeline Progress and Milestone Expectations for 2022

January 10, 2022

Fulcrum Therapeutics

Fulcrum Therapeutics® Announces Upcoming Milestones to Support Its Mission of Treating the Root Cause of Rare Genetic Diseases

January 04, 2022

Allena Pharmaceuticals

Allena Pharmaceuticals Provides Clinical and Corporate Update

January 04, 2022

Fulcrum Therapeutics

Fulcrum Therapeutics® Appoints Esther Rajavelu as Chief Financial Officer

Load More

Sign up for weekly portfolio news.